Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Biochemistry and Cell Biology

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.biocel.2008.05.026PMID 18725319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immobilised metal affinity chromatography for the capture of hydroxamate-containing siderophores and other Fe(III)-binding metabolites directly from bacterial culture supernatants.

  2008cited by this paper
• Traversing the coordination chemistry and chemical biology of hydroxamic acids

  2008cited by this paper
• Human HDAC7 Harbors a Class IIa Histone Deacetylase-specific Zinc Binding Motif and Cryptic Deacetylase Activity*

  2008cited by this paper
• Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases

  2007cited by this paper
• Activity-based probes for proteomic profiling of histone deacetylase complexes

  2007cited by this paper
• The therapeutic uses of chromatin-modifying agents

  2007cited by this paper
• Histone deacetylase inhibitors: molecular mechanisms of action

  2007cited by this paper
• CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues

  2006cited by this paper
• Anticancer activities of histone deacetylase inhibitors

  2006cited by this paper
• Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors

  2006cited by this paper
• Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

  2006cited by this paper
• Crystal structure of a bacterial class 2 histone deacetylase homologue.

  2005cited by this paper
• Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

  2004cited by this paper
• Histone deacetylases (HDACs): characterization of the classical HDAC family.

  2003cited by this paper
• Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA.

  2003cited by this paper
• CASTp: Computed Atlas of Surface Topography of proteins

  2003cited by this paper
• Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR.

  2002cited by this paper
• Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

  1999cited by this paper
• A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

  1998cited by this paper
• A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p

  1996cited by this paper
• [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A].

  1990cited by this paper
• Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

  1990cited by this paper

• Design, Synthesis and Anti Cancer Evaluation of novel 1, 3, 4-oxadiazoles

  2025cites this paper
• The Drosophila histone variant H2Av facilitates Notch signaling activity in a two-tier regulatory fashion

  2025cites this paper
• Cytotoxic, anti-inflammatory, antioxidant, and anti-glyoxalase-I evaluation of chelating substances: In silico and in vitro study

  2025cites this paper
• Metal Ion Signaling in Biomedicine

  2025cites this paper
• Diversified applications and synthesis of hydroxamic acids

  2024cites this paper
• Double‐strand DNA break repair: molecular mechanisms and therapeutic targets

  2023cites this paper
• Trichostatin A enhances the titanium rods osseointegration in osteoporotic rats by the inhibition of oxidative stress through activating the AKT/Nrf2 pathway

  2023cites this paper
• Screening for eukaryotic motifs in Legionella pneumophila reveals Smh1 as bacterial deacetylase of host histones

  2022cites this paper
• Discovery of a novel HDACi structure that inhibits the proliferation of ovarian cancer cells in vivo and in vitro

  2021cites this paper
• Delivery systems for vorinostat in cancer treatment: An updated review

  2021cites this paper
• CYP2C9 inhibits the invasion and migration of esophageal squamous cell carcinoma via downregulation of HDAC

  2021cites this paper
• Effect of vorinostat on INK4 family and HDACs 1, 2, and 3 in pancreatic cancer and hepatocellular carcinoma

  2021cites this paper
• Effect of the hydroxamate group in the antitumoral activity and toxicity toward normal cells of new copper(II) complexes

  2021cites this paper
• Histone deacetylase 10, a potential epigenetic target for therapy

  2021cites this paper
• Epigenética del cáncer de mama

  2020cites this paper
• SAHA and EGCG Promote Apoptosis in Triple-negative Breast Cancer Cells, Possibly Through the Modulation of cIAP2

  2020cites this paper
• Epigenetic Mechanisms Underlying Organic Solute Transporter β Repression in Colorectal Cancer

  2020cites this paper
• Histone modification as a potential preventative and therapeutic approach for cardiovascular disease

  2020cites this paper
• Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy

  2020cites this paper
• Role of histone deacetylases in the pathogenesis of kidney diseases

  2019cites this paper
• Epigenetic regulation of myelination in health and disease

  2019cites this paper
• The P-glycoprotein inhibitor diltiazem-like 8-(4-chlorophenyl)-5-methyl-8-[(2Z)-pent-2-en-1-yloxy]-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one inhibits esterase activity and H3 histone acetylation.

  2019cites this paper
• Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes

  2019cites this paper
• BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo

  2019cites this paper
• Exploring hydroxamic acid inhibitors of HDAC1 and HDAC2 using small molecule tools and molecular or homology modelling.

  2019cites this paper
• Design, synthesis and evaluation of belinostat analogs as histone deacetylase inhibitors.

  2019cites this paper
• Histone Deacetylase Modifications by Probiotics in Colorectal Cancer

  2019cites this paper
• Histone Deacetylase Inhibitors in Tumor Immunotherapy.

  2019cites this paper
• Histone deacetylase inhibitors as a new anticancer option : How far can we go with expectations ?

  2018cites this paper
• Novel histone deacetylase inhibitors and embryo aggregation enhance cloned embryo development and ES cell derivation in pigs

  2018cites this paper
• Histone deacetylase inhibitor stimulates E2 and P4 secretion in sika deer ovarian granulosa cells at a moderate dose

  2018cites this paper
• Inhibition of histone deacetylase 7 reverses concentrative nucleoside transporter 2 repression in colorectal cancer by up‐regulating histone acetylation state

  2018influential citation
• A novel HDAC6 inhibitor exerts an anti‐cancer effect by triggering cell cycle arrest and apoptosis in gastric cancer

  2018cites this paper
• HDAC Inhibitors: Novel Immunosuppressants for Allo‐ and Xeno‐ Transplantation

  2018cites this paper
• ING5‐mediated antineuroblastoma effects of suberoylanilide hydroxamic acid

  2018cites this paper
• A comprehensive evaluation of Hippo pathway silencing in sarcomas

  2018cites this paper
• HDACis (class I), cancer stem cell, and phytochemicals: Cancer therapy and prevention implications.

  2017cites this paper
• Green Synthesis of Hydroxamic Acid and Its Potential Industrial Applications

  2017cites this paper
• Investigating the mechanism of cellular gene activation and repression by the EBV transcription factor EBNA 2

  2017cites this paper
• Catalyst selection by transition state affinity chromatography—An assessment

  2017cites this paper
• Novel histone deacetylase inhibitor N25 exerts anti-tumor effects and induces autophagy in human glioma cells by inhibiting HDAC3

  2017cites this paper
• Reverse Biosynthesis: Generating Combinatorial Pools of Drug Leads from Enzyme‐Mediated Fragmentation of Natural Products

  2017cites this paper
• Loss of Elp3 Impairs the Acetylation and Distribution of Connexin-43 in the Developing Cerebral Cortex

  2017cites this paper
• The in vitro and vivo anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) and MG132 on the aggressive phenotypes of gastric cancer cells

  2016cites this paper
• Dysregulation of Acetylation Enzymes in Animal Models of Psychostimulant use Disorders: Evolving Stories

  2016cites this paper
• Differential Expression of mRNAs Coding for Histone Deacetylases (HDACs) in the Nucleus Accumbens of Compulsive Methamphetamine Takers and Abstinent Rats

  2016cites this paper
• Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge

  2016cites this paper
• Epigenetic regulations by insulin and histone deacetylase inhibitors of the insulin signaling pathway in muscle

  2016cites this paper
• Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review

  2015cites this paper
• Augmentation of Cationic Antimicrobial Peptide Production with Histone Deacetylase Inhibitors as a Novel Epigenetic Therapy for Bacterial Infections

  2015cites this paper
• Attenuation of Choroidal Neovascularization by Histone Deacetylase Inhibitor

  2015cites this paper
• Novel targets in pancreatic cancer research.

  2015cites this paper
• Breast Cancer Epigenetics

  2015cites this paper
• HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements

  2015cites this paper
• Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease

  2015cites this paper
• Targeting Histone Deacetylases in Diseases: Where Are We?

  2015cites this paper
• Introducing enteral feeding induces intestinal subclinical inflammation and respective chromatin changes in preterm pigs.

  2015cites this paper
• Differential effects of binge methamphetamine injections on the mRNA expression of histone deacetylases (HDACs) in the rat striatum.

  2014cites this paper
• Combination Therapy for Cancer: Phototherapy and HDAC Inhibition

  2014cites this paper
• Enhancing SCNT with Chromatin Remodeling Agents

  2014cites this paper
• Histone deacetylase inhibitors potentiate photochemotherapy in cutaneous T-cell lymphoma MyLa cells.

  2014cites this paper
• Suberoylanilide hydroxamic acid suppresses inflammation-induced neovascularization.

  2014cites this paper
• Matrix Revisited: Mechanisms Linking Energy Substrate Metabolism to the Function of the Heart

  2014cites this paper
• The role of acetylation in the regulation of antimicrobial peptide gene expression in the human intestine

  2014cites this paper
• New Applications of Immobilized Metal Ion Affinity Chromatography in Chemical Biology

  2014cites this paper
• Natural compounds in epigenetics: a current view.

  2014cites this paper
• Therapy for Latent HIV-1 Infection: The Role of Histone Deacetylase Inhibitors

  2014cites this paper
• Epigenetic modulators from "The Big Blue": a treasure to fight against cancer.

  2014cites this paper
• Epigenetics of Stress, Addiction, and Resilience: Therapeutic Implications

  2014cites this paper
• Epigenetic targeting in pancreatic cancer.

  2014influential citation
• Histone deacetylase inhibitors and pancreatic cancer: are there any promising clinical trials?

  2013cites this paper
• Valproic Acid Treatment from the 4-cell Stage Improves Oct4 Expression and Nuclear Distribution of Histone H3K27me3 in Mouse Cloned Blastocysts

  2013cites this paper
• Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies

  2013cites this paper
• Multiple Aspects of Gene Dysregulation in Huntington’s Disease

  2013cites this paper
• Inactivation of HDAC3 and STAT3 is Critically Involved in 1-Stearoyl-sn-Glycero-3-Phosphocholine-Induced Apoptosis in Chronic Myelogenous Leukemia K562 Cells

  2013cites this paper
• Current evidence for histone deacetylase inhibitors in pancreatic cancer.

  2013cites this paper
• Efficient tumor targeting by anaerobic butyrate-producing bacteria.

  2013cites this paper
• Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function.

  2013cites this paper
• Hydroxamic Acid Derivatives as Potential Anticancer Agents

  2013cites this paper
• Cultured Cells by Valproic Acid Inhibition of Enveloped Virus Infection of

  2013cites this paper
• Solution species of Fe(III), Ga(III), In(III) or Ln(III) and suberodihydroxamic acid from electrospray ionization mass spectrometry

  2013cites this paper
• Treatment Options in Motor Neuron Disease: Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy

  2012cites this paper
• Valuable insight into the anticancer activity of the platinum-histone deacetylase inhibitor conjugate, cis-[Pt(NH3)2malSAHA-2H)].

  2012cites this paper
• Regulation of leptin receptor expression in human papillary thyroid cancer cells.

  2012cites this paper
• Synergetic effects of DNA demethylation and histone deacetylase inhibition in primary rat hepatocytes

  2012cites this paper
• Different effects of histone deacetylase inhibitors nicotinamide and trichostatin A (TSA) in C17.2 neural stem cells

  2012cites this paper
• Reduced Histone H3K9 Acetylation of Clock Genes and Abnormal Glucose Metabolism in ob/ob Mice

  2012cites this paper
• Emerging targeted therapies for lymphoid malignancies.

  2012cites this paper
• SAHA, an HDAC inhibitor, synergizes with tacrolimus to prevent murine cardiac allograft rejection

  2012cites this paper
• Hydroxamic acid – A novel molecule for anticancer therapy

  2012cites this paper
• Genetic Knock-Down of Hdac3 Does Not Modify Disease-Related Phenotypes in a Mouse Model of Huntington's Disease

  2012cites this paper
• Decapping of long noncoding RNAs regulates inducible genes.

  2012cites this paper
• Zinc Sensing Receptor Signaling, Mediated by GPR39, Reduces Butyrate-Induced Cell Death in HT29 Colonocytes via Upregulation of Clusterin

  2012cites this paper
• Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects.

  2012cites this paper
• Analytical-scale purification of trichostatin A from bacterial culture in a single step and with high selectivity using immobilised metal affinity chromatography

  2012cites this paper
• How Histone Deacetylases Control Myelination

  2011cites this paper
• Genetics Primer for the General Cardiologist Epigenetic Modifications Basic Mechanisms and Role in Cardiovascular Disease

  2011cites this paper
• Genetics Primer for the General Cardiologist

  2011cites this paper
• SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease

  2011cites this paper
• Transcriptional modulation of monoaminergic neurotransmission genes by the histone deacetylase inhibitor trichostatin A in neuroblastoma cells

  2011cites this paper